Cliff Asness's CDNA Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 303,035 shares of CareDx, Inc. (CDNA) worth $5.71 M, representing 0.00% of the portfolio. First purchased in 2018-Q2, this long-term strategic position has been held for 31 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in CDNA, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 248,519 shares. Largest reduction occurred in Q2 2024, reducing 269,082 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's CareDx (CDNA) Holding Value Over Time
Track share changes against reported price movement
Quarterly CareDx (CDNA) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +115,122 | Add 61.26% | 303,035 | $18.84 |
| Q3 2025 | -71,850 | Reduce 27.66% | 187,913 | $14.54 |
| Q2 2025 | -200,123 | Reduce 43.52% | 259,763 | $19.54 |
| Q1 2025 | -87,384 | Reduce 15.97% | 459,886 | $17.75 |
| Q4 2024 | +217,476 | Add 65.94% | 547,270 | $21.41 |
| Q3 2024 | +149,735 | Add 83.16% | 329,794 | $31.23 |
| Q2 2024 | -269,082 | Reduce 59.91% | 180,059 | $15.53 |
| Q1 2024 | +248,519 | Add 123.87% | 449,141 | $10.59 |
| Q4 2023 | -115,820 | Reduce 36.60% | 200,622 | $12.00 |
| Q3 2023 | -20,894 | Reduce 6.19% | 316,442 | $7.00 |
| Q2 2023 | +227,709 | Add 207.71% | 337,336 | $8.50 |
| Q1 2023 | +56,959 | Add 108.15% | 109,627 | $9.14 |
| Q4 2022 | +21,661 | Add 69.86% | 52,668 | $11.41 |
| Q3 2022 | +31,007 | New Buy | 31,007 | $17.03 |
| Q2 2022 | -22,771 | Sold Out | 0 | $0.00 |
| Q1 2022 | -3,842 | Reduce 14.44% | 22,771 | $36.98 |
| Q4 2021 | -961 | Reduce 3.49% | 26,613 | $45.47 |
| Q3 2021 | -566 | Reduce 2.01% | 27,574 | $63.36 |
| Q2 2021 | -2,819 | Reduce 9.11% | 28,140 | $91.51 |
| Q1 2021 | +7,615 | Add 32.62% | 30,959 | $68.09 |
| Q4 2020 | +8,489 | Add 57.15% | 23,344 | $72.44 |
| Q3 2020 | +1,220 | Add 8.95% | 14,855 | $37.97 |
| Q2 2020 | +929 | Add 7.31% | 13,635 | $35.42 |
| Q1 2020 | -38,532 | Reduce 75.20% | 12,706 | $21.80 |
| Q4 2019 | -94,048 | Reduce 64.73% | 51,238 | $21.57 |
| Q3 2019 | -200,187 | Reduce 57.95% | 145,286 | $22.61 |
| Q2 2019 | -31,411 | Reduce 8.33% | 345,473 | $35.99 |
| Q1 2019 | +70,269 | Add 22.92% | 376,884 | $31.52 |
| Q4 2018 | +110,316 | Add 56.20% | 306,615 | $25.14 |
| Q3 2018 | +26,101 | Add 15.34% | 196,299 | $28.85 |
| Q2 2018 | +170,198 | New Buy | 170,198 | $12.24 |
Cliff Asness's CareDx Investment FAQs
Cliff Asness first purchased CareDx, Inc. (CDNA) in Q2 2018, acquiring 170,198 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held CareDx, Inc. (CDNA) for 31 quarters since Q2 2018.
Cliff Asness's largest addition to CareDx, Inc. (CDNA) was in Q1 2024, adding 449,141 shares worth $4.76 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 303,035 shares of CareDx, Inc. (CDNA), valued at approximately $5.71 M.
As of the Q4 2025 filing, CareDx, Inc. (CDNA) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in CareDx, Inc. (CDNA) was 547,270 shares, as reported at the end of Q4 2024.